Evidence map›Paper›PMID 42454161›Full record

ReviewJournal of inflammation research2026

Microplastics, Gut Dysbiosis, and Inflammatory Pathways in Ulcerative Colitis.

Yalong Chen, Xudong Tian

Abstract readReview
In one paragraph

Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yalong ChenCollege of Integrated Traditional Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu, People's Republic of China.
Xudong TianGastrospleen Disease Diagnosis and Treatment Center, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou, Gansu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microplastics (MPs) are pervasive environmental pollutants characterized by their widespread distribution. They can enter the human body through multiple routes, including inhalation and dietary intake, accumulate in the gastrointestinal tract, and subsequently disrupt intestinal microecological homeostasis, thereby contributing to digestive diseases. Ulcerative colitis (UC), a chronic inflammatory bowel disease of unclear etiology, has been closely associated with gut microbiota dysbiosis, which is considered one of its central pathogenic mechanisms. This review comprehensively review the fundamental characteristics of MPs and their interactions with the gut microbiota and microbial metabolites. It further elucidates the key mechanisms by which MPs mediate the initiation and progression of UC, with particular emphasis on intestinal mucosal barrier dysfunction and immune dysregulation. Mechanistically, MPs disrupt SCFAs-producing microbial networks and activate epithelial inflammatory pathways, particularly TLR4-NF-κB signaling, thereby amplifying mucosal inflammation in UC. This review is the first to completely connect the regulatory axis of MPs - gut microbiota - metabolites - intestinal barrier - immune inflammation, clarify the core pathological chain of UC induced by MPs, make up for the shortcomings of existing reviews that only conduct single-dimensional analysis and lack integration of complete mechanisms, and provide a new theoretical framework for this field. Additionally, current research limitations are discussed, and future research directions and potential intervention strategies are proposed, aiming to provide novel theoretical insights into the etiology and prevention of UC.

Indexed as

gut microbiotaimmunityinflammatorymicroplasticsulcerative colitis

Identifiers

PMID42454161
PMCPMC13367360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.